Unique ID issued by UMIN | UMIN000017769 |
---|---|
Receipt number | R000020583 |
Scientific Title | Ezetimibe lipid lowering trial on cholesterol absorption-synthesis and prevention of atherrosclerosis in 75 or older with hight risk hyper LDL cholesterolemia |
Date of disclosure of the study information | 2015/06/02 |
Last modified on | 2015/06/02 11:14:54 |
Ezetimibe lipid lowering trial on cholesterol absorption-synthesis and prevention of atherrosclerosis in 75 or older with hight risk hyper LDL cholesterolemia
KEEP(Kyushu Elderly Ezetimibe Phytosterol study)
Ezetimibe lipid lowering trial on cholesterol absorption-synthesis and prevention of atherrosclerosis in 75 or older with hight risk hyper LDL cholesterolemia
KEEP(Kyushu Elderly Ezetimibe Phytosterol study)
Japan |
Hyper-LDL-cholesterolemia
Medicine in general | Hepato-biliary-pancreatic medicine | Cardiology |
Endocrinology and Metabolism | Neurology | Geriatrics |
Others
NO
To investigate the effects of ezetimibe on cholesterol absorption-synthesis and inflammation markers and cardiovascular events.
Efficacy
Confirmatory
Pragmatic
Not applicable
0 to 24weeks
(1)changes in cholesterol absorption and synthesis
(2)changes in inflammation markers
(3)changes in lipoproteins(RLPcholesterol, small dense LDL etc),
oxydised phospholipid, oxdised cholesterol)
(4)NT-proBNP
relation to composite
cardiovascular events(same as EWTOPIA75)
Interventional
Parallel
Randomized
Individual
Open -but assessor(s) are blinded
Active
YES
YES
Institution is considered as adjustment factor in dynamic allocation.
NO
Central registration
2
Treatment
Medicine |
ezetimibe and diet
diet
75 | years-old | <= |
Not applicable |
Male and Female
(1) High-risk outpatients with hyper-LDL-cholesterolemia (serum LDL-cholesterol levels 140mg/dL) aged 75 years and older (at the time of written informed consent) of the both sexes (LDL-cholesterol levels are calculated with Friedewald Formula).
(2) At least one of the following factors
1. DM
2. Hypertension
3. Low-HDL-cholesterolemia
4. Hypertriglyceridemia
5. Current smoking
6. History of cerebral infarction
7. PAD
(1)Serum TG level400 mg/dL
(2) History of myocardial infarction
(3) History of PCI or CABG
(4) Angina pectoris requiring treatment
(5) Recent history of stroke(within 6 months)
(6) 1. AST100 IU/L 2. ALT100 IU/L 3. liver chirosis
(7) Serum creatinine level3.0 mg/dL
(8) Cancer
(9) Dementia
(10) Familial hyperchoresterolemia
(11) Atrial fibrillation
(12) Allergy to ezetimibe
(13) Patients participating in other clinical trials
(14) Patients inappropriate for the trial judged by investigators
1300
1st name | |
Middle name | |
Last name | Jun Sasaki,MD,PhD |
International University of Health and Welfare
Department of medical treatment for health
2-4-16 Momochihama Sawaraku,Fukuoka,Japan
092-407-0434
fukuoka-shiken@iuhw.ac.jp
1st name | |
Middle name | |
Last name | Jun Sasaki,MD,PhD |
International University of Health and Welfare
Department of medical treatment for health
2-4-16 Momochihama Sawaraku,Fukuoka,Japan
092-407-0434
fukuoka-shiken@iuhw.ac.jp
International University of Health and Welfare
International University of Health and Welfare
Other
Japan
NO
国際医療福祉大学
2015 | Year | 06 | Month | 02 | Day |
Unpublished
No longer recruiting
2015 | Year | 03 | Month | 24 | Day |
2015 | Year | 04 | Month | 01 | Day |
2017 | Year | 12 | Month | 31 | Day |
2015 | Year | 06 | Month | 02 | Day |
2015 | Year | 06 | Month | 02 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000020583
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |